Your browser doesn't support javascript.
loading
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials.
Platzbecker, U; Fenaux, P; Adès, L; Giagounidis, A; Santini, V; van de Loosdrecht, A A; Bowen, D; de Witte, T; Garcia-Manero, G; Hellström-Lindberg, E; Germing, U; Stauder, R; Malcovati, L; Sekeres, Mikkael A; Steensma, David P; Gloaguen, S.
Affiliation
  • Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany.
  • Fenaux P; European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
  • Adès L; European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
  • Giagounidis A; Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, and Université Paris 7, Paris, France.
  • Santini V; European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
  • van de Loosdrecht AA; Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, and Université Paris 7, Paris, France.
  • Bowen D; European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
  • de Witte T; Klinik für Onkologie, Hämatologie und Palliativmedizin, Marien Hospital, Düsseldorf, Germany.
  • Garcia-Manero G; European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
  • Hellström-Lindberg E; Azienda Ospedaliero Universitaria (AOU) Careggi, University of Florence, Florence, Italy.
  • Germing U; European Myelodysplastic Syndromes Cooperative Group (EMSCO Group), Leipzig, Germany.
  • Stauder R; Department of Haematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Malcovati L; St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Sekeres MA; Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Steensma DP; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Gloaguen S; Division of Haematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Blood ; 133(10): 1020-1030, 2019 03 07.
Article in En | MEDLINE | ID: mdl-30404811
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Clinical Trials as Topic / Hematology Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: Blood Year: 2019 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Clinical Trials as Topic / Hematology Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: Blood Year: 2019 Type: Article Affiliation country: Germany